Zhu L - Search Results

1

Evaluation of Prognostic Nutritional Index in Patients Undergoing Radical Surgery with Nonsmall Cell Lung Cancer.

Qiu C, Qu X, Shen H, Zheng C, Zhu L, Meng L, Du J. Qiu C, et al. Among authors: zhu l. Nutr Cancer. 2015;67(5):741-7. doi: 10.1080/01635581.2015.1032430. Epub 2015 May 5. Nutr Cancer. 2015. PMID: 25941961

2

Intratumoral neutrophil granulocytes contribute to epithelial-mesenchymal transition in lung adenocarcinoma cells.

Hu P, Shen M, Zhang P, Zheng C, Pang Z, Zhu L, Du J. Hu P, et al. Among authors: zhu l. Tumour Biol. 2015 Sep;36(10):7789-96. doi: 10.1007/s13277-015-3484-1. Epub 2015 May 6. Tumour Biol. 2015. PMID: 25944163

3

β-arrestin1 over-expression is associated with an unfavorable prognosis in lung adenocarcinomas and correlated with vascular endothelial growth factor.

Qiu C, Zheng C, Zhu L, Qu X, Shen H, Du J. Qiu C, et al. Among authors: zhu l. Int J Clin Exp Pathol. 2015 Apr 1;8(4):3785-93. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26097560 Free PMC article.

4

Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer.

Cao H, Dong W, Shen H, Xu J, Zhu L, Liu Q, Du J. Cao H, et al. Among authors: zhu l. PLoS One. 2015 Aug 19;10(8):e0135844. doi: 10.1371/journal.pone.0135844. eCollection 2015. PLoS One. 2015. PMID: 26287334 Free PMC article.

5

The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies.

Zhu L, Cao H, Zhang T, Shen H, Dong W, Wang L, Du J. Zhu L, et al. Medicine (Baltimore). 2016 Apr;95(17):e3528. doi: 10.1097/MD.0000000000003528. Medicine (Baltimore). 2016. PMID: 27124062 Free PMC article. Review.

6

Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC.

Cao H, Dong W, Qu X, Shen H, Xu J, Zhu L, Liu Q, Du J. Cao H, et al. Among authors: zhu l. Sci Rep. 2016 Aug 4;6:31072. doi: 10.1038/srep31072. Sci Rep. 2016. PMID: 27488947 Free PMC article.

7

Adverse Events and Efficacy of Cixutumumab in Phase II Clinical Trials: A systematic Review and Meta-Analysis.

Cao H, Cui L, Ma W, Zhu L, Wang K, Ni Y, Wang Y, Du J. Cao H, et al. Among authors: zhu l. Clin Drug Investig. 2017 Feb;37(2):135-153. doi: 10.1007/s40261-016-0475-y. Clin Drug Investig. 2017. PMID: 27858328 Review.

8

Expressions of insulin-like growth factor receptor-1 and cezanne-1 in lung adenocarcinoma.

Pang Z, Cui L, Ding N, Zhu L, Qu X, Dong W, Du J, Liu Q. Pang Z, et al. Among authors: zhu l. Med Oncol. 2017 May;34(5):78. doi: 10.1007/s12032-017-0934-1. Epub 2017 Apr 1. Med Oncol. 2017. PMID: 28365890

9

Comparison of the short-term clinical outcome between open and minimally invasive esophagectomy by comprehensive complication index.

Ma G, Cao H, Wei R, Qu X, Wang L, Zhu L, Du J, Wang Y. Ma G, et al. Among authors: zhu l. J Cancer Res Ther. 2018;14(4):789-794. doi: 10.4103/jcrt.JCRT_48_18. J Cancer Res Ther. 2018. PMID: 29970654 Free article.

10

Cezanne contributes to cancer progression by playing a key role in the deubiquitination of IGF-1R.

Chen X, Pang Z, Wang Y, Zhu L, Liu J, Du J. Chen X, et al. Among authors: zhu l. Am J Cancer Res. 2020 Dec 1;10(12):4342-4356. eCollection 2020. Am J Cancer Res. 2020. PMID: 33415003 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,974 results

Search Page

Filters